Gynura segetum-induced liver injury leading to acute liver failure: a case report and literature review

[1] Lin G(2011)Hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum J Hepatol 54 666-673

[2] Wang JY(2019)Gynura Segetum related hepatic sinusoidal obstruction syndrome: a liver disease with high mortality and misdiagnosis rate Curr Pharm Des 25 3762-3768

[3] Li N(2014)Tusanqi and hepatic sinusoidal obstruction syndrome J Dig Dis 15 105-107

[4] Li M(2013)Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland Gastroenterology 144 1419-1425

[5] Gao H(2014)Practice Parameters Committee of the American College of G: ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury Am J Gastroenterol 109 950-966

[6] Ji Y(2012)An update on drug-induced liver injury J Clin Exp Hepatol 2 247-259

[7] Zhang F(2019)Drug-induced liver injury — types and phenotypes N Engl J Med 381 264-273

[8] Wang H(2004)Pyrrolizidine alkaloids–genotoxicity, metabolism enzymes, metabolic activation, and mechanisms Drug Metab Rev 36 1-55

[9] Zhou Y(2000)Support of sinusoidal endothelial cell glutathione prevents hepatic veno-occlusive disease in the rat Hepatology 31 428-434

[10] Ye Y(1999)Characterization of a reproducible rat model of hepatic veno-occlusive disease Hepatology 29 1779-1791

[1] Lin G(2011)Hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum J Hepatol 54 666-673

[2] Wang JY(2019)Gynura Segetum related hepatic sinusoidal obstruction syndrome: a liver disease with high mortality and misdiagnosis rate Curr Pharm Des 25 3762-3768

[3] Li N(2014)Tusanqi and hepatic sinusoidal obstruction syndrome J Dig Dis 15 105-107

[4] Li M(2013)Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland Gastroenterology 144 1419-1425

[5] Gao H(2014)Practice Parameters Committee of the American College of G: ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury Am J Gastroenterol 109 950-966

[6] Ji Y(2012)An update on drug-induced liver injury J Clin Exp Hepatol 2 247-259

[7] Zhang F(2019)Drug-induced liver injury — types and phenotypes N Engl J Med 381 264-273

[8] Wang H(2004)Pyrrolizidine alkaloids–genotoxicity, metabolism enzymes, metabolic activation, and mechanisms Drug Metab Rev 36 1-55

[9] Zhou Y(2000)Support of sinusoidal endothelial cell glutathione prevents hepatic veno-occlusive disease in the rat Hepatology 31 428-434

[10] Ye Y(1999)Characterization of a reproducible rat model of hepatic veno-occlusive disease Hepatology 29 1779-1791